Clinical Trials · NCT00669162

Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer

Name: Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1/Phase 2Gonadorelin

Phase: Phase 1/Phase 2
Recruitment status: Completed
Sponsor: University of Kansas Medical Center
Enrollment: 27
Start date: Aug 2012
Locations: 1 site, United States
Primary endpoint: Percentage of Patients Who Can Safely Tolerate and Complete Adjuvant Hormonal Therapy, Radiation Therapy and Docetaxel After a Radical Prostatectomy

View Gonadorelin compound reference